BLB-750 Vaccine (Qinghai RG strain)
BLB-750/CCT-901
Approved mab completed
Quick answer
BLB-750 Vaccine (Qinghai RG strain) for Pandemic Influenza Prevention is a Approved program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Pandemic Influenza Prevention
- Phase
- Approved
- Modality
- mab
- Status
- completed